Why Investors Shouldn't Be Surprised By Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) P/S

Simply Wall St.01-21

When you see that almost half of the companies in the Pharmaceuticals industry in Hong Kong have price-to-sales ratios (or "P/S") below 2.3x, Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) looks ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2605112825?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2026-01-21 06:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605112825","market":"nz","top_or_hot":-1,"title":"Why Investors Shouldn't Be Surprised By Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) P/S","media":"Simply Wall St.","content":"<div>\n<p>When you see that almost half of the companies in the Pharmaceuticals industry in Hong Kong have price-to-sales ratios (or \"P/S\") below 2.3x, Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) looks ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/why-investors-shouldnt-be-surprised-by-sihuan-pharmaceutical\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Investors Shouldn't Be Surprised By Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) P/S</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Investors Shouldn't Be Surprised By Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) P/S\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-21 06:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/why-investors-shouldnt-be-surprised-by-sihuan-pharmaceutical><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When you see that almost half of the companies in the Pharmaceuticals industry in Hong Kong have price-to-sales ratios (or \"P/S\") below 2.3x, Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) looks ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/why-investors-shouldnt-be-surprised-by-sihuan-pharmaceutical\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1600","symbol_name":"工业大麻","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/why-investors-shouldnt-be-surprised-by-sihuan-pharmaceutical","article_id":"2605112825","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/why-investors-shouldnt-be-surprised-by-sihuan-pharmaceutical","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2605112825","pubTimestamp":1768947107,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"When you see that almost half of the companies in the Pharmaceuticals industry in Hong Kong have price-to-sales ratios...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1600":"工业大麻","00460":"四环医药","ISBC":"投资者银行","BK1191":"制药","BK4211":"区域性银行","BK1515":"抗疫概念","BK1593":"医美概念股"},"translate_title":"为什么投资者不应该对四环医药控股集团有限公司（HKG：460）的市盈率感到惊讶","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00460":1,"ISBC":1.5},"content_text":"When you see that almost half of the companies in the Pharmaceuticals industry in Hong Kong have price-to-sales ratios (or \"P/S\") below 2.3x, Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) looks to be giving off strong sell signals with its 4.9x P/S ratio.   However, the P/S might be quite high for a reason and it requires further investigation to determine if it's justified.    Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.  See our latest analysis for Sihuan Pharmaceutical Holdings Group SEHK:460 Price to Sales Ratio vs Industry January 20th 2026Advertisement What Does Sihuan Pharmaceutical Holdings Group's P/S Mean For Shareholders?  Sihuan Pharmaceutical Holdings Group certainly has been doing a good job lately as it's been growing revenue more than most other companies.   It seems that many are expecting the strong revenue performance to persist, which has raised the P/S.  However, if this isn't the case, investors might get caught out paying too much for the stock.      Want the full picture on analyst estimates for the company? Then our free report on Sihuan Pharmaceutical Holdings Group will help you uncover what's on the horizon.   Is There Enough Revenue Growth Forecasted For Sihuan Pharmaceutical Holdings Group?   In order to justify its P/S ratio, Sihuan Pharmaceutical Holdings Group would need to produce outstanding growth that's well in excess of the industry.   If we review the last year of revenue growth, the company posted a terrific increase of 20%.   Still, revenue has fallen 19% in total from three years ago, which is quite disappointing.  Therefore, it's fair to say the revenue growth recently has been undesirable for the company.     Shifting to the future, estimates from the dual analysts covering the company suggest revenue should grow by 33% over the next year.  That's shaping up to be materially higher than the 14% growth forecast for the broader industry.  In light of this, it's understandable that Sihuan Pharmaceutical Holdings Group's P/S sits above the majority of other companies.  Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.    What We Can Learn From Sihuan Pharmaceutical Holdings Group's P/S?  Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.  Our look into Sihuan Pharmaceutical Holdings Group shows that its P/S ratio remains high on the merit of its strong future revenues.  It appears that shareholders are confident in the company's future revenues, which is propping up the P/S.  It's hard to see the share price falling strongly in the near future under these circumstances.      The company's balance sheet is another key area for risk analysis.  Take a look at our free balance sheet analysis for Sihuan Pharmaceutical Holdings Group with six simple checks on some of these key factors.   If companies with solid past earnings growth is up your alley, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios. New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605112825","isCrawlerRequest":true}